Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
49.5M
-
Shares change
-
+10.6M
-
Total reported value, excl. options
-
$251M
-
Value change
-
+$53.7M
-
Put/Call ratio
-
1.35
-
Number of buys
-
62
-
Number of sells
-
-43
-
Price
-
$5.07
Significant Holders of ImmunityBio, Inc. - COM (IBRX) as of Q4 2022
151 filings reported holding IBRX - ImmunityBio, Inc. - COM as of Q4 2022.
ImmunityBio, Inc. - COM (IBRX) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.5M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (8.26M shares), CVI Holdings, LLC (7.61M shares), BlackRock Inc. (7.02M shares), STATE STREET CORP (6.74M shares), GEODE CAPITAL MANAGEMENT, LLC (2.03M shares), SHEETS SMITH WEALTH MANAGEMENT (1.54M shares), JPMORGAN CHASE & CO (1.53M shares), GOLDMAN SACHS GROUP INC (1.15M shares), Balyasny Asset Management LLC (897K shares), and PICTET ASSET MANAGEMENT SA (846K shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.